BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin

Multinuclear platinum complexes represent a new class of anticancer agents, distinct in terms of DNA binding features and the profile of antitumor activity from their mononuclear counterparts, in particular cisplatin. Among complexes of this class, BBR 3464, a trinuclear platinum compound has been s...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical cancer research Vol. 6; no. 7; p. 2626
Main Authors:	Manzotti, C, Pratesi, G, Menta, E, Di Domenico, R, Cavalletti, E, Fiebig, H H, Kelland, L R, Farrell, N, Polizzi, D, Supino, R, Pezzoni, G, Zunino, F
Format:	Journal Article
Language:	English
Published:	United States 01.07.2000
Subjects:	Animals Antineoplastic Agents - toxicity Carcinoma, Small Cell - drug therapy Carcinoma, Small Cell - pathology Cell Cycle - drug effects Cell Survival - drug effects Cisplatin - toxicity Drug Screening Assays, Antitumor Female Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Melanoma Mice Mice, Nude Organoplatinum Compounds - toxicity Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Tumor Cells, Cultured Xenograft Model Antitumor Assays
ISSN:	1078-0432
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!